Related Experiment Videos
The hypoxic tumour microenvironment and metastatic progression.
Patrick Subarsky1, Richard P Hill
1Experimental Therapeutics Divison, Ontario Cancer Institute/Princess Margaret Hospital, Department of Medical Biophysics, University of Toronto, Canada.
Clinical & Experimental Metastasis
|May 14, 2003
Summary
Hypoxia, or low oxygen, in tumors drives cancer metastasis through epigenetic changes. Understanding these hypoxia-induced gene expression alterations is key to developing new anti-metastasis therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Solid tumors often feature hypoxic (low oxygen) and acidic microenvironments.
- Emerging evidence highlights hypoxia's critical role in cancer metastasis.
- Hypoxia can induce genomic instability and epigenetic alterations in tumor cells.
Purpose of the Study:
- To review the epigenetic mechanisms by which the hypoxic tumor microenvironment influences gene expression.
- To explore the contribution of these hypoxia-driven epigenetic changes to metastatic progression.
Main Methods:
- Literature review of clinical and experimental studies on hypoxia and metastasis.
- Analysis of recent advances in high-throughput screening for hypoxia-induced genes.
- Focus on epigenetic control of gene expression in the context of metastasis.
Main Results:
- Hypoxia promotes genomic instability and heterogeneity, acting as a selective pressure.
- Epigenetic modifications by hypoxia alter gene expression, affecting stress responses, metabolism, angiogenesis, tissue remodeling, and cell-cell contacts.
- Identification of numerous hypoxia-induced genes involved in metastatic processes.
Conclusions:
- Epigenetic regulation by the hypoxic tumor microenvironment is a significant contributor to metastatic progression.
- Targeting hypoxia-induced epigenetic changes presents a potential therapeutic strategy against cancer metastasis.